Low brain expression of the spermidine/spermine N-1 acetyltransferase (SAT1) gene, the rate-limiting enzyme involved in catabolism of polyamines that mediate the polyamine stress response (PSR), has been reported in depressed suicides. However, it is unknown whether this effect is associated with depression or with suicide and whether all or only specific isoforms expressed by SAT1, such as the primary 171 amino acid proteinencoding transcript (SSAT), or an alternative splice variant (SSATX) that is involved in SAT1 regulated unproductive splicing and transcription (RUST), are involved. We applied next generation sequencing (RNA-seq) to assess gene-level, isoform-level, and exon-level SAT1 expression differences between healthy controls (HC, N = 29), DSM-IV major depressive disorder suicides (MDD-S, N = 21) and MDD non-suicides (MDD, N = 9) in the dorsal lateral prefrontal cortex (Brodmann Area 9, BA9) of medication-free individuals postmortem. Using small RNAseq, we also examined miRNA species putatively involved in SAT1 post-transcriptional regulation. A DSM-IV diagnosis was made by structured interview. Toxicology and history ruled out recent psychotropic medication. At the gene-level, we found low SAT1 expression in both MDD-S (vs. HC, p = 0.002) and MDD (vs. HC, p = 0.002). At the isoform-level, reductions in MDD-S (vs. HC) were most pronounced in four transcripts including SSAT and SSATX, while reductions in MDD (vs. HC) were pronounced in three transcripts, one of which was reduced in MDD relative to MDD-S (all p b 0.1 FDR corrected). We did not observe evidence for differential exon-usage (i.e. splicing) nor differences in miRNA expression. Results replicate the finding of low SAT1 brain expression in depressed suicides in an independent sample and implicate low SAT1 brain expression in MDD independent of suicide. Low expressions of both SSAT and SATX isoforms suggest that shared transcriptional mechanisms involved in RUST may account for low SAT1 brain expression in depressed suicides. Future studies are required to understand the functions and regulation of SAT1 isoforms, and how they relate to the pathogenesis of MDD and suicide.
Introduction
Involvement of the polyamine system in suicide was first suggested by a reported deficit in spermidine/spermine N-1 acetyltransferase (SAT1), the rate-limiting enzyme in the catabolism of polyamines spermidine and spermine in the polyamine stress response (PSR), in multiple brain regions of suicides (Sequeira et al., 2006) . In this study, an exploratory whole-genome approach (Affymetrix HG-U133A cDNA microarray) identified low SAT1 mRNA levels in suicides, and low mRNA and protein levels were confirmed by semiquantitative reverse transcription-polymerase chain reaction (RT-PCR), immunohistochemistry and Western blot analyses (Sequeira et al., 2006) . Low SAT1 expression in the brain has been confirmed by other groups in both depressed and non-depressed suicides (Sequeira et al., 2007; Guipponi et al., 2009; Klempan et al., 2009a,b) . Conversely, higher SAT1 has been found in the blood of suicidal attempters, non-attempters who are suicide ideators and suicides with bipolar disorder or psychosis (Le-Niculescu et al., 2013) , providing further evidence for a role of SAT1 dysregulation in suicidal behavior. What is not clear is whether this abnormality is also present in major depressive disorder independently of suicidal behavior.
Microarray studies of the brains of suicides have identified more potentially responsible genes and molecular pathways, including SAT1 and the polyamine system (Fiori and Turecki, 2010a). However, hybridization-based methods have several limitations, which include reliance upon existing knowledge about genome sequence, high background levels due to cross-hybridization (Okoniewski and Miller, 2006; Royce et al., 2007) , and a limited dynamic range of detection 
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